股本结构
单位：万股
| 公告日期 | 2026-08-06 | 2026-08-06 | 2026-05-12 | 2026-05-12 | 2026-03-31 | 2026-03-05 |
|---|---|---|---|---|---|---|
| 证券总股本 | 6157.46 | 6146.96 | 6141.65 | 6141.44 | 6141.44 | 6130.64 |
| 普通股本 | 6157.46 | 6146.96 | 6141.65 | 6141.44 | 6141.44 | 6130.64 |
| 优先股 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 其他 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 变动日期 | 2026-08-04 | 2026-06-30 | 2026-05-08 | 2026-03-31 | 2026-03-20 | 2026-03-02 |
注释：中概股证券总股本=普通股股本/
存托凭证比例
历史变动
| 公告日期 | 变动后普通股本（万股） | 变动后优先股（万股） | 变动原因 | 变动日期 |
|---|---|---|---|---|
| 2026-08-06 | 6157.46 | 未披露 | 定期报告 | 2026-08-04 |
| 2026-08-06 | 6146.96 | 未披露 |
更多>>
From March 31,2026 to June 30,2026
Exercise of options and vesting of restricted stock units
|
2026-06-30 |
| 2026-05-12 | 6141.65 | 未披露 | 定期报告 | 2026-05-08 |
| 2026-05-12 | 6141.44 | 未披露 |
更多>>
From December 31, 2025 to March 31, 2026
Exercise of options and vesting of restricted stock units
Issuance of common stock through employee stock purchase plan
Proceeds from the issuance of common stock, net of issuance costs
|
2026-03-31 |
| 2026-03-31 | 6141.44 | 未披露 | 定期报告 | 2026-03-20 |
| 2026-03-05 | 6130.64 | 未披露 | 定期报告 | 2026-03-02 |
| 2026-02-20 | 5981.16 | 未披露 |
更多>>
Common Stock offered 9,756,100 shares by the company
|
2026-02-23 |
| 2026-02-19 | 5005.55 | 未披露 | 定期报告 | 2026-01-31 |
| 2026-03-05 | 4999.78 | 未披露 |
更多>>
From December 31, 2024 to December 31, 2025
Preferred stock conversion
Exercise of options and vesting of restricted stock units
Issuance of common stock through employee stock purchase plan
Proceeds from sale of common stock
Preferred stock conversion
|
2025-12-31 |
| 2025-11-13 | 4996.43 | 未披露 | 定期报告 | 2025-11-10 |
| 2025-11-13 | 4989.13 | 未披露 |
更多>>
From June 30, 2025 to September 30, 2025
Exercise of options and vesting of restricted stock units
Issuance of common stock through employee stock purchase plan
Preferred stock conversion
|
2025-09-30 |
| 2025-08-12 | 4986.73 | 未披露 | 定期报告 | 2025-08-06 |
| 2025-08-12 | 3798.33 | 359.40 |
更多>>
From March 31, 2025 to June 30, 2025
Exercise of options
Proceeds from sale of common stock
Preferred stock conversion
|
2025-06-30 |
| 2025-06-23 | 3797.58 | 未披露 | 定期报告 | 2025-06-13 |
| 2025-05-15 | 3783.90 | 未披露 | 定期报告 | 2025-05-09 |
| 2025-04-30 | 3233.52 | 359.40 | 定期报告 | 2025-04-17 |
| 2025-05-15 | 3227.25 | 362.00 |
更多>>
From December 31, 2024 To March 31, 2025
Preferred stock conversion
Exercise of options
|
2025-03-31 |
| 2025-04-15 | 3127.93 | 398.50 |
更多>>
From December 31, 2023 to December 31, 2024
Exercise of options
Proceeds from sale of common stock
Issuance of common stock for exchange warrants
Preferred stock conversion
|
2024-12-31 |
| 2024-11-14 | 3049.31 | 未披露 | 定期报告 | 2024-11-08 |
| 2024-10-29 | 3049.11 | 未披露 | 定期报告 | 2024-10-21 |
| 2024-11-14 | 3046.97 | 398.50 |
更多>>
From June 30, 2024 to September 30, 2024
Exercise of options
Issuance of common stock for exchange warrants
Proceeds from sale of common stock
Preferred stock conversion
|
2024-09-30 |
| 2024-08-14 | 2931.15 | 未披露 | 定期报告 | 2024-08-09 |
| 2024-07-01 | 2926.97 | 未披露 |
更多>>
July 1,2024,TriSalus Life Sciences Inc. Issued 2,110,366 shares of the Company's common stock.
|
2024-07-01 |
| 2024-07-19 | 2715.95 | 401.50 | 定期报告 | 2024-06-26 |
| 2024-05-15 | 2715.93 | 未披露 | 定期报告 | 2024-05-08 |
| 2024-04-11 | 2675.83 | 未披露 | 定期报告 | 2024-04-03 |
| 2024-05-15 | 2675.83 | 401.50 |
更多>>
From December 31, 2023 to March 31, 2024
Exercise of options
Proceeds from sale of common stock
|
2024-03-31 |
| 2024-04-11 | 2641.32 | 401.50 |
更多>>
From December 31, 2022 to December 31, 2023
Conversion of redeemable convertible preferred stock into common stock in connection with the Business Combination
Assumption of preferred stock in connection with the Business Combination
Exercise of options
Issuance of common stock upon closing the Business Combination, net of expenses
|
2023-12-31 |
| 2023-12-26 | 2641.32 | 未披露 | 定期报告 | 2023-12-21 |
| 2023-12-15 | 2638.73 | 未披露 | 定期报告 | 2023-12-08 |
| 2023-11-14 | 2631.67 | 401.50 |
更多>>
From June 30, 2023 to September 30, 2023
Assumption of preferred stock in connection with the Business Combination
Exercise of options
Issuance of common stock upon closing the Business Combination, net of expenses
Conversion of redeemable convertible preferred stock into common stock in connection with the Business Combination
|
2023-09-30 |
| 2023-07-18 | 3007.75 | 未披露 | 定期报告 | 2023-08-11 |
| 2023-08-02 | 739.48 | 未披露 |
更多>>
From March 31, 2023 to June 30, 2023
Class B common stock converted into Class A common stock
|
2023-06-30 |
| 2023-03-22 | 820.34 | 未披露 | 定期报告 | 2022-12-31 |
| 2021-06-28 | 3125.00 | 未披露 |
更多>>
From January 1, 2021 To March 31, 2021
Change in value of common stock subject to redemption
|
2021-03-31 |
| 2021-03-31 | 3125.00 | 未披露 | 定期报告 | 2021-03-29 |
| 2020-12-21 | 2750.00 | 未披露 | 定期报告 | 2021-02-08 |
From March 31,2026 to June 30,2026
Exercise of options and vesting of restricted stock units
From December 31, 2025 to March 31, 2026
Exercise of options and vesting of restricted stock units
Issuance of common stock through employee stock purchase plan
Proceeds from the issuance of common stock, net of issuance costs
Common Stock offered 9,756,100 shares by the company
From December 31, 2024 to December 31, 2025
Preferred stock conversion
Exercise of options and vesting of restricted stock units
Issuance of common stock through employee stock purchase plan
Proceeds from sale of common stock
Preferred stock conversion
From June 30, 2025 to September 30, 2025
Exercise of options and vesting of restricted stock units
Issuance of common stock through employee stock purchase plan
Preferred stock conversion
From March 31, 2025 to June 30, 2025
Exercise of options
Proceeds from sale of common stock
Preferred stock conversion
From December 31, 2024 To March 31, 2025
Preferred stock conversion
Exercise of options
From December 31, 2023 to December 31, 2024
Exercise of options
Proceeds from sale of common stock
Issuance of common stock for exchange warrants
Preferred stock conversion
From June 30, 2024 to September 30, 2024
Exercise of options
Issuance of common stock for exchange warrants
Proceeds from sale of common stock
Preferred stock conversion
July 1,2024,TriSalus Life Sciences Inc. Issued 2,110,366 shares of the Company's common stock.
From December 31, 2023 to March 31, 2024
Exercise of options
Proceeds from sale of common stock
From December 31, 2022 to December 31, 2023
Conversion of redeemable convertible preferred stock into common stock in connection with the Business Combination
Assumption of preferred stock in connection with the Business Combination
Exercise of options
Issuance of common stock upon closing the Business Combination, net of expenses
From June 30, 2023 to September 30, 2023
Assumption of preferred stock in connection with the Business Combination
Exercise of options
Issuance of common stock upon closing the Business Combination, net of expenses
Conversion of redeemable convertible preferred stock into common stock in connection with the Business Combination
From March 31, 2023 to June 30, 2023
Class B common stock converted into Class A common stock
From January 1, 2021 To March 31, 2021
Change in value of common stock subject to redemption